Why Healthcare Providers Are Well Positioned to Talk to Patients About Medical Marijuana
Healthcare providers cannabis policy clarifies that discussing medical marijuana with patients is legally permissible despite federal restrictions on prescribing. This distinction encourages open, informed conversations to guide patient use safely.…
TGA officials to join cannabis prescribers for annual ANZCCP conference – Cannabiz
✦ New CED Clinical Relevance #61 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchIndustrySafetyClinical PracticeRegulationProfessional Development Why This Matters # Clinical…
Americans support cannabis rescheduling, study finds – EurekAlert!
Cannabis rescheduling clinical implications extend beyond regulatory changes to fundamentally reshape research access and patient care protocols. Healthcare providers must prepare for evolving practice standards as federal policy aligns with growing…
US DEA medical marijuana registration portal to launch Wednesday – Virginia Lawyers Weekly
The DEA's new medical marijuana registration portal requirements represent a significant shift in federal cannabis oversight for healthcare providers. This centralized system could streamline physician access while establishing clearer regulatory…
Did President Donald Trump accidentally legalize medical marijuana in South Carolina?
Complex federal cannabis policy changes may create unexpected pathways for medical marijuana access in traditionally restrictive states. Understanding these regulatory intersections requires clinical guidance to navigate safely. Patients need clear legal…
Endocannabinoid System Research and Medical Cannabis Dosing Guide – CED Clinic
Understanding endocannabinoid system medical cannabis dosing is essential for optimizing therapeutic outcomes in cannabis medicine. The ECS's role in homeostasis explains individual dosing variations and therapeutic windows. Clinical success requires…
Why the future of marijuana legalization remains hazy despite high public support
Cannabis legalization implementation challenges continue to create barriers between public support and actual patient access to medical cannabis. Complex regulatory frameworks and federal-state conflicts complicate clinical decision-making and treatment…
After moves to protect medical marijuana, Trump asks Congress to save hemp
Understanding hemp versus medical marijuana clinical differences is crucial as federal policy developments affect patient access and treatment options. Hemp-derived CBD offers non-intoxicating therapeutic benefits, while medical marijuana provides…
Federal Marijuana Rescheduling Will End Discrimination In Housing, Healthcare And …
Federal cannabis rescheduling patient discrimination policies may soon change as marijuana moves from Schedule I to Schedule III classification. This regulatory shift could eliminate systematic barriers that medical cannabis patients face in housing,…
Medicinal Cannabis Prescription Before an Inpatient Psychiatric Admission: A Retrospective Observational Audit.
Prescribing of medicinal cannabis has expanded in Australia; however, evidence for benefit in psychiatric populations is limited. The goal of this study was ...